Snapshot of COVID-19 Related Clinical Trials in India
- PDF / 208,995 Bytes
- 5 Pages / 595.276 x 790.866 pts Page_size
- 30 Downloads / 199 Views
ORIGINAL RESEARCH ARTICLE
Snapshot of COVID-19 Related Clinical Trials in India Jaykaran Charan1 • Rimplejeet Kaur2 • Pankaj Bhardwaj3 • Tanuj Kanchan4 Prasenjit Mitra5 • Dharmveer Yadav5 • Praveen Sharma5 • Sanjeev Misra6
•
Received: 18 July 2020 / Accepted: 4 August 2020 Ó Association of Clinical Biochemists of India 2020
Abstract Many interventions are being explored for the prophylaxis and treatment of COVID-19 in all over the world including India. There was a need of systematic data about the COVID-19 related clinical trials conducted in India. The aim of the present study was to analyze various clinical trials registered in Clinical Trial Registry of India (CTRI) exploring the interventions for COVID 19. The data of various clinical trials being conducted in India was obtained from CTRI. Different trial characteristics were extracted in the predesigned proforma and analyzed. Values were expressed in frequency and percentages. As of 11th July, 2020, a total of 203 trials were registered in the CTRI. The majority of the trials (61%) were related to the AYUSH interventions. Only 3 trials were international while the others were national. A major portion of public and private funding were dedicated to the AYUSH trials. More number of trials were for treatment as compared to prophylaxis. Maharashtra and Delhi are having highest number of trial sites. There is a good progress regarding & Jaykaran Charan [email protected] 1
Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India
2
Department of Pharmacology, S.N. Medical College, Jodhpur, India
3
Department of Community and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India
4
Department of Forensic Medicine, All India Institute of Medical Sciences, Jodhpur, India
5
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
6
Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India
AYUSH clinical trials, and a similar progress is expected for allopathic interventions. Keywords COVID 19 Trials AYUSH Treatment Prophylaxis
Introduction COVID-19 is a pandemic that emerged in the majority of the countries after its origin in Wuhan, China. India is amongst the countries having a high number of cases and looking at the current trend; it could be soon in the top spot in terms of cases [1, 2]. Observing the morbidity and mortality associated with COVID-19, it is going to have a long-lasting effect on the people, policymakers, doctors etc. As happened in most of the emerging diseases, there is no treatment or prevention modality available which is based on the principle of evidence based medicine (EBM). In view of this, lot of research is happening all over the world to generate evidences for new treatment modalities and diagnostics for COVID19. There were around 60 COVID-19 related clinical trials in January 2020 which increased to around 4000 in first week of July [3]. A number of significant and important trials have already done interim
Data Loading...
